Discover 4,560 paid clinical trials in Texas. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Sponsor:
AbbVie
Location:
Code:
NCT04064827
Conditions
Chronic Kidney Disease (CKD)
Secondary Hyperparathyroidism (SHPT)
Eligibility Criteria
Sex: All
Age: 0 - 9
Healthy Volunteers: Not accepted
Interventions
Paricalcitol
Sponsor:
M.D. Anderson Cancer Center
Location:
Code:
NCT01515527
Conditions
Leukemia
Eligibility Criteria
Sex: All
Age: 60+
Healthy Volunteers: Not accepted
Interventions
Cladribine
Cytarabine
Decitabine
Sponsor:
Ribon Therapeutics, Inc.
Location:
Code:
NCT04053673
Conditions
Solid Tumor, Adult
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
RBN-2397
Sponsor:
Edwards Lifesciences
Location:
Code:
NCT05172973
Conditions
Aortic Valve Insufficiency
Aortic Valve Stenosis
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
SAPIEN X4 THV
Sponsor:
Takeda
Location:
Code:
NCT04844073
Conditions
Squamous Cell Cancer of Head and Neck (SCCHN)
Non-small Cell Lung Cancer (NSCLC)
Colorectal Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
TAK-186
Sponsor:
Gilead Sciences
Location:
Code:
NCT03547973
Conditions
Metastatic Urothelial Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Sacituzumab Govitecan-hziy
Pembrolizumab
Cisplatin
Avelumab
Zimberelimab
Sponsor:
American Thrombosis and Hemostasis Network
Location:
Code:
NCT04647227
Conditions
Hemophilia A With Inhibitor
Hemophilia B With Inhibitor
Eligibility Criteria
Sex: All
Age: 12 - 70+
Healthy Volunteers: Not accepted
Interventions
coagulation factor VIIa [recombinant]-jncw
Sponsor:
M.D. Anderson Cancer Center
Location:
Code:
NCT03295227
Conditions
Stage III Thymoma AJCC v8
Stage IIIA Thymoma AJCC v8
Stage IIIB Thymoma AJCC v8
Stage IV Thymoma AJCC v8
Stage IVA Thymoma AJCC v8
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Pembrolizumab
Sponsor:
Kowa Research Institute, Inc.
Location:
Code:
NCT05327127
Conditions
NASH
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
K-877-ER
CSG452
Placebo
Sponsor:
Y-mAbs Therapeutics
Location:
Code:
NCT03363373
Conditions
Neuroblastoma
Eligibility Criteria
Sex: All
Age: 1+
Healthy Volunteers: Not accepted
Interventions
GM-CSF + Naxitamab
With a broad healthcare network and leading medical research centers, Texas is a key location for a wide range of clinical trials. Major institutions such as MD Anderson Cancer Center, Baylor College of Medicine, UT Southwestern Medical Center, and Texas Heart Institute are at the forefront of these studies.
Texas offers unique advantages for those participating in clinical trials. The state's diverse population provides a broad range of participants, which enhances the reliability and relevance of research findings. Texas is also known for its innovative research environment, with a strong focus on medical advancements and cutting-edge studies.
By choosing to participate in a clinical trial in Texas, you contribute to important medical research while benefiting from a well-established and supportive clinical research system.
Clinical trials in Texas cover a broad range of health conditions, offering participants the opportunity to contribute to medical advancements while accessing innovative treatments.
Texas is home to world-leading cancer research institutions, making it a key location for oncology trials. These trials offer access to innovative treatments, such as new drugs, immunotherapies, and advanced radiation techniques that are not yet widely available.
As a major center for oncology research, Texas conducts clinical trials that cover a broad spectrum of cancers, including breast cancer, lung cancer, leukemia, colorectal cancer, prostate cancer, and liver cancer. These trials emphasize the development of targeted therapies, advancements in immunotherapy, and the exploration of combination treatments to improve the effectiveness of current cancer treatments.
Texas plays a major role in researching treatments for neurological conditions, particularly in areas such as stroke prevention, Alzheimer’s disease, Parkinson's disease, epilepsy, multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS).
Clinical trials in these areas focus on developing innovative therapies, such as new drugs, brain stimulation devices, and gene therapies, with the goal of slowing disease progression and improving early intervention strategies.
Heart disease is a leading cause of death across the United States, making cardiovascular clinical trials a top priority in Texas. These studies investigate conditions such as heart failure, coronary artery disease, hypertension, and atrial fibrillation.
Research centers are dedicated to developing new treatments and improving preventative measures to combat this widespread health issue, with the goal of reducing its impact on millions of people. Innovations being tested include next-generation heart devices, new cholesterol-lowering medications, and minimally invasive cardiovascular procedures, all aimed at reducing the impact of these conditions on the population.
Chronic conditions such as diabetes and obesity are significant health challenges across the United States. Clinical trials in Texas are essential for advancing the management and treatment of these widespread issues.
These trials play an important role in evaluating new diabetes medications, exploring weight-loss therapies, and developing advanced treatments for respiratory and kidney diseases. By focusing on these areas, Texas contributes to improving care and outcomes for long-term health conditions like Type 1 and Type 2 diabetes, asthma, and chronic obstructive pulmonary disease (COPD).
Infectious diseases remain a critical area of study in Texas, especially given the state’s role in COVID-19 vaccine research and other viral disease treatments. Several prominent research institutions and hospitals in Texas, such as The University of Texas Medical Branch (UTMB) in Galveston, Baylor College of Medicine in Houston, and the Texas Biomedical Research Institute in San Antonio, were involved in key phases of vaccine trials.
In addition to its significant role in the initial development of COVID-19 vaccines, clinical trials in the state are also focusing on several key areas such as evaluating the efficacy of antiviral drugs, and exploring new strategies for HIV/AIDS prevention. Research efforts also encompass other important areas such hepatitis C, tuberculosis, and influenza, aiming to improve treatments and prevention methods for these prevalent infectious diseases.
With rising awareness of mental health challenges, Texas is a growing center for clinical research aimed at improving treatment options for psychiatric and behavioral disorders. Clinical trials explore both pharmaceutical solutions and therapeutic interventions.
Clinical trials address conditions such as depression, anxiety disorders, PTSD, schizophrenia, and bipolar disorder. These studies focus on testing novel antidepressants, anxiety-reducing therapies, and psychotherapies, aiming to provide better treatment options for individuals facing mental health challenges.
Texas also supports clinical trials for rare diseases, offering new hope to patients with conditions that have limited treatment options. These studies often focus on genetic conditions and explore groundbreaking treatments like gene therapy.
Clinical trials cover conditions such as cystic fibrosis, Duchenne muscular dystrophy, rare cancers, and other inherited disorders. Research efforts focus on gene editing, enzyme replacement therapies, and drug development, pushing forward groundbreaking treatments for these often overlooked diseases.
In Texas, clinical trials are governed by strict local regulations and guidelines to ensure the highest standards of safety and ethics. The Texas Department of State Health Services oversees clinical trials to ensure they adhere to state and federal standards. Researchers must obtain Institutional Review Board (IRB) approval, which involves a thorough review of the study’s design, risks, and benefits to protect participant welfare.
Informed consent is a crucial element for participants, ensuring they receive detailed information about the trial's purpose, procedures, potential risks, and benefits before agreeing to take part. Additionally, stringent privacy regulations are in place to protect the confidentiality of participants' medical information, upholding high standards of data security throughout the research process.
Participating in clinical trials offers numerous benefits, including access to cutting-edge treatments and therapies that are not yet available to the general public. Participants often receive close monitoring and care from top medical professionals, ensuring a high level of attention and support throughout the study.
Additionally, involvement in clinical trials contributes to important medical research that can lead to advancements in treatment and care for future patients. By participating, individuals not only gain early access to potentially groundbreaking interventions but also play an important role in advancing scientific knowledge and improving healthcare outcomes for others.
Worried about the risks of participating in a clinical trial? Read our comprehensive guide to gain insights into the potential outcomes of participating. Learn about potential risks, benefits, and safety considerations to make an informed decision about your participation in a clinical trial.
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started: